News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Yara Aceta, Product Manager de Bioherent
#NewAseBioMember | “AseBio likely serves as an essential platform for industry collaboration, innovation support, and regulatory guidance in Spain’s biotech sector”
Corporate
Meet BIOHERENT, our new member. We spoke with Yara Aceta, Product Manager.
Científico investigando con un microscopio
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current landscape of cancer treatment
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
Biotechnology has radically changed the treatment of many types of tumors, evolving from highly…
Miguel Molina, Sales Manager Chemical & Pharma de GEA
#NewAseBioMember | “AseBio is a key meeting point for the biotechnology sector in Spain”
Corporate
Meet GEA, our new member. We spoke with Miguel Molina, Sales Manager Chemical…
Logo del European Innovation Council (EIC)
The EIC identifies biotechnology for its potential to contribute to European competitiveness
Healthcare · Access to innovation · Agrifood · Industrial biotechnology
This report aims to provide an overview of the most promising emerging developments to serve as a…
Lidya Domínguez, directora de Investigación Clínica de Sermes CRO
January 30: A key date for clinical research in europe: the transition to CTIS will mark a turning point
Healthcare · Access to innovation · Industrial biotechnology · EU projects
We interviewed Lidya Domínguez, Director of Clinical Research at Sermes CRO, experts in European…
Muestras de laboratorio
Spain, the EU leader in 2024 in advanced therapy research, with a growing prominence of biotechnological medicines
Healthcare · Advanced therapies
Out of the 930 studies authorized by the AEMPS last year, a total of 52 focused on advanced therapy…
Guillermo Rodriguez Lázaro, Director Científico de Grupo AIA
#NewAseBioMember | “AseBio is a key player in the growth of biotechnology in Spain”
Corporate
Meet Grupo AIA, our new member. We spoke with Guillermo Rodriguez Lázaro, Chief…
javier ruiz sanz pharmaron
#NewAseBioMember | “AseBio represents more than just an association; it's a catalyst for collaboration, innovation, and growth within the Spanish biotech landscape”
Healthcare · Drug discovery · International
Meet Pharmaron, our new member. We spoke with Javier Ruiz Sanz, Associate Director – Business…
Alejandro Rodriguez UCO
#NewAseBioMember | “AseBio is a biotechnology-related partnership that can serve to increase knowledge transfer from university to business”
Communication · Services
Meet Universidad de Córdoba, our new member. We spoke with Alejandro Rodríguez Pascual, General…